Phenobarbital

One of the oldest antiepileptic drugs still in clinical use, phenobarbital is a Schedule IV barbiturate requiring therapeutic drug monitoring to maintain serum concentrations within the target range and minimize dose-related toxicity. Laboratory testing applications include drugs of abuse screening, forensic toxicology investigations, postmortem toxicology, and clinical toxicology assessments in emergency departments evaluating suspected barbiturate overdose or sedative-hypnotic toxicity. UTAK’s Barbiturates Panel, DAU, and Urine Drug Screen panels contain phenobarbital in lyophilized serum and urine matrices at multiple concentration levels, supporting both immunoassay screening and confirmation methods used in clinical and forensic laboratories. Stock and custom QC solutions can incorporate related barbiturates such as pentobarbital, secobarbital, amobarbital, butalbital, and other commonly monitored sedative-hypnotics to address your laboratory’s comprehensive antiepileptic therapeutic drug monitoring and drugs of abuse testing requirements.